The Coca-Cola Company (NYSE:KO) is a fixture in many dividend portfolios, and for good reason. Its lineup of household names and dependable demand has supported a remarkable track record of dividend hikes. But with shares trading at a premium, it’s fair to ask if the company’s growth and cash flow can keep up with its valuation.
Coca-Cola’s reach is hard to overstate: the company sells drinks in over 200 countries and territories. From classics like Coca-Cola, Sprite, and Fanta to Powerade and fairlife, the company covers just about every beverage category, from sodas to water, sports drinks, tea, and dairy. Its biggest advantages remain brand recognition, a global distribution system, and tight partnerships with bottlers, all of which help keep the business resilient.
The latest numbers back up the company’s reputation for consistency. In Q2 2026, revenue climbed 7% year-over-year to $13.38 billion, with organic sales up 6%. Global unit case volume increased 5%, and comparable EPS rose 11% to $0.97. Management nudged full-year guidance higher, now looking for around 5% organic revenue growth and 9-10% EPS growth. For dividend investors, these results are encouraging, though headwinds like currency swings and rising costs shouldn’t be ignored.
Read more: Coca-Cola (KO) Posted 5% Volume Growth in Q2, Does Its Multiple Already Price It In?
Pixabay/Public Domain
A Dividend Built on Decades of Consistency
In February 2026, The Coca-Cola Company increased its quarterly dividend by about 4%, moving it from $0.51 to $0.53 per share. That brings the annual payout to $2.12, an impressive streak of 64 straight years of hikes. At a recent price of $87.77, the yield comes out to roughly 2.4%.
Importantly, KO’s dividend is backed by solid cash flow. In the first half of 2026, operating cash flow reached $7.5 billion, with free cash flow coming in at $6.9 billion. Management expects about $12.4 billion in free cash flow this year. The $2.12 annual dividend represents about 64% of trailing diluted EPS of $3.33, leaving space for reinvestment and possible future increases.
Coca-Cola paid out $4.56 billion in dividends in the first half of the year, though timing quirks can make quarter-to-quarter comparisons tricky. Ultimately, the real question is whether profit and free cash flow will keep up at a pace that allows for more dividend hikes without stretching the balance sheet. Jim Cramer also thinks KO’s dividend should not be overlooked. Read here.
A Rich Multiple Meets Modest Revenue Growth
The Coca-Cola Company stock commands a premium, reflecting investor confidence in its stable earnings and business model. Still, revenue growth has been steady rather than spectacular, moving from $45.75 billion in 2023 to $47.94 billion in 2025. That’s a sign of strong pricing power and reach, but also a reminder that the company isn’t growing rapidly. To justify its valuation, KO will likely need to lean on price increases, product mix improvements, and better margins, not just volume gains.
Coca-Cola’s trailing P/E is 26.61, and its forward P/E is 25.32, both above the projections for the end of 2025. The small gap between these numbers suggests analysts expect some earnings growth, but not enough to meaningfully reduce valuation concerns. Investors are still paying a premium for the company’s reliability.
A forward P/E of 25.32 yields an earnings yield of about 3.95%, up from 3.76% based on trailing earnings. While that’s not especially high compared to Treasuries, especially since Treasuries don’t carry equity risk, Coca-Cola offers something bonds don’t: the potential for earnings and dividend growth over time.
Conclusion
Coca-Cola’s valuation seems reasonable as long as it delivers on earnings growth and keeps its competitive edge. But with only moderate revenue growth and a relatively low earnings yield, there may not be much upside in valuation unless the company outperforms. For now, it’s a high-quality dividend stock with a premium price tag, not a bargain, but not a stretch for those seeking stability.
READ NEXT: Is Parker Hannifin’s Premium Valuation a Warning Sign for Dividend Investors? and Abbott Laboratories is More than a Dividend Stock. Here’s Why.
This article is originally published at Insider Monkey.
